Huakang Biomedical Holdings Company Limited 華康生物醫學控股有 限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 FIRST QUARTERLY REPORT 第一季業績報告 2021 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 ANNUAL REPORT 年報 2020 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors shoul ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 2020 Third Quarterly Report 第三季業績報告 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 2020 Interim Report 中期業績報告 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other com ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 2020 First Quarterly Report 第一季業績報告 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限 公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 ANNUAL REPORT 2019 年報 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 ANNUAL REPORT 2019 年報 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized c ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 20 19 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be aware of the ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 INTERIM REPORT 中期業績報告 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 20 19 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other comp ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 FIRST QUARTERLY REPORT 第一季度業績報告 20 19 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than ...

Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 (incorporated in the Cayman Islands with limited liability) (於開曼群島註冊成立之有限公司) Stock Code 股份代號: 8622 ANNUAL REPORT 年 報 20 18 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 司 ANNUAL REPORT 2018 年報 Huakang Biomedical Holdings Company Limited 華康生物醫學控股有限公 This Report, for which the Directors (the "Directors") of Huakang Biomedical Holdings Company Limited (the "Company", and together with its subsidiaries, the "Group", "we" or "our") collectively ...